Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Audit (A-06-06-00093)

Ochsner Health Plan of Louisiana's Adjusted Community Rate Proposal Modifications for Contract Year 2004

Executive Summary

Ochsner Health Plan of Louisiana's (Ochsner) proposed uses of approximately $36 million of the $41 million estimated Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) payment increase in contract year 2004 for three plans were supported and allowable under the MMA. However, Ochsner's proposed uses of $4.7 million for one of the three plans were not allowable because, contrary to Centers for Medicare & Medicaid Services (CMS) instructions, these funds related to mandatory supplemental benefits. In addition, because of a clerical error, Ochsner overstated by an estimated $95,000 its proposed use of the payment increase to enhance benefits for another plan.

We recommended that Ochsner follow CMS instructions and guidance when preparing future proposals (now referred to as "bids") and ensure that amounts included in the proposals are allowable. In written comments on our draft report, Humana, Inc., which acquired Ochsner, did not agree that Ochsner's proposed uses of $4.7 million of the MMA payment increase for mandatory supplemental benefits were unallowable. Humana did not address our finding that Ochsner overstated proposed enhanced benefits by $95,000. Because Humana believed that Ochsner followed CMS guidance in preparing its revised proposal, Humana did not agree with our recommendation. Humana did not provide any additional information that would cause us to change our findings or recommendation.

Complete Report

Download the complete report (PDF)

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201